| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.1 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.26 | 0.1 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.085 | 0.1 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.19 | 0.1 |